Complex treatment for people with health conditions link to type 2 diabetes available for GPs to access in “bitesize” chunks.
Recommendations of care for people with type 2 diabetes and other health conditions including cardiovascular disease have been published in an accessible format to “navigate the complexities” of the treatment.
The guidance has been compiled by a global team of medical experts who were led by researchers from the NIHR Applied Research Collaboration (ARC) East Midlands and featured in a recently published report in Primary Care Diabetes.
The document includes guidance for several chronic health conditions that people with type 2 diabetes are more likely to develop, with a particular focus on cardiovascular disease, the collective name for problems related to the heart and blood vessels, including coronary heart disease.
Around 30% of people living with type 2 diabetes are estimated to be affected by cardiovascular disease and it is a major cause of death.
More people are being diagnosed with type 2 diabetes and the report acknowledges that often people with the condition have additional chronic health complaints - which have become a challenge for doctors to treat correctly based on individual needs.
Samuel Seidu, study lead author, GP and Clinical Lecturer at the University of Leicester, said: “Type 2 diabetes and its associated health complications are growing more prevalent, and we’re finding that many healthcare professionals working in primary care require help to navigate the complexities of managing the condition.
“New and emerging medical therapies and evidence have changed the landscape of treating type 2 diabetes. There is now a plethora of available treatment options, which combined with GP appointment time restraints, can make prescribing the correct medication for more than one condition quite challenging.
“The guidance we’ve drawn up offers a simple and patient-centred clinical decision-making model with practical treatment options specifically for healthcare professionals working in primary care.”
The guidance provides a breakdown of side effects and risk factors for a wide variety of type 2 diabetes therapies, in addition to positive benefits of different medications.
Professor Kamlesh Khunti
Professor Kamlesh Khunti, Director of NIHR Applied Research Collaboration (ARC) East Midlands and Professor of Primary Care, Diabetes and Vascular Medicine at the University of Leicester, said: “Type 2 diabetes can be successfully managed, and its associated complications prevented, especially if detected and treated early. However, understanding the complexity of the disease and the pharmacological options is critical for ensuring optimal patient care and improving outcomes.
“Cardiovascular disease affects nearly one-third of all people with type 2 diabetes globally, so therefore a comprehensive diabetes management plan is needed for healthcare professionals so they can educate their patients into making informed decisions, helping them to succeed in reaching their glycaemic target goals and prevent the number and complexity of serious complications.”
Read the report in Primary Care Diabetes
Support DRWF by making a donation here
Find out more about DRWF-funded research here
Read Latest changes in guidance in shielding and protecting people at high risk of Covid-19 including people with diabetes
DRWF operations during the Covid-19 health crisis
The DRWF team is now working remotely. Covid-19 guidance, particularly where it aligns or impacts with diabetes guidance, is shared as quickly as possible through the DRWF website and social media channels with the aim of making it as easy to understand as possible and a reliable source of latest news.
To receive the charity’s latest bulletins as they become available, please sign up here
Subscribe to Diabetes Wellness News here